Diagnostics News and Research

RSS

NanoString Technologies to present clinical study of Prosigna Breast Cancer Assay at ASCO 2013

NanoString Technologies, Inc., a privately held provider of life science tools for translational research and molecular diagnostic products, today announced that a clinical study of the Prosigna Breast Cancer Assay will be presented during the Breast Cancer Oral Abstract Session at the 2013 Annual American Society of Clinical Oncology Meeting on Sunday, June 2.

From NanoString Technologies 1 Jun 2013

Experts to kick off Big Ten Cancer Research Consortium in Chicago

In athletics, the Big Ten universities compete against each other, but now many will join together against a common foe: cancer.

1 Jun 2013

Five studies on breast, colon and colorectal cancer to be presented at ASCO Annual Meeting

Agendia, a world leader in molecular cancer diagnostics, today announced that results from five studies focused on breast, colon and colorectal cancer will be presented at the upcoming American Society of Clinical Oncology Annual Meeting to be held May 31-June 4, 2013 at McCormick Place in Chicago.

1 Jun 2013

Viral load: A new technique that helps doctors diagnose chronic viral diseases

To test the severity of a viral infection, clinicians try to gauge how many viruses are packed into a certain volume of blood or other bodily fluid. This measurement, called viral load, helps doctors diagnose or monitor chronic viral diseases such as HIV/AIDS and hepatitis.

31 May 2013

Be ready for the next generation of cancer treatments

We cordially invite you to attend Markers in Cancer, a joint meeting by ASCO, EORTC & NCI which will be held 7 - 9 November 2013 in Brussels.

31 May 2013

Apnix Sleep Diagnostics updates comprehensive sleep apnea treatments

Apnix Sleep Diagnostics has recently updated its comprehensive sleep apnea treatments, and is eager to serve more Houston sufferers of this condition.

31 May 2013

GE Healthcare receives FDA clearance for Brivo Plus C-arm

GE Healthcare announced today FDA 510(k) clearance of its latest Brivo Plus C-arm, now available in the US. With legacy OEC image quality and ease-of-use, the affordability and reliability of this new Brivo C-arm will offer a high quality, affordable option for basic surgical imaging.

31 May 2013

Cedars-Sinai team awarded grant to study cardiac stem cell treatment for Duchenne muscular dystrophy

Newport Beach-based nonprofit Coalition Duchenne has awarded a $150,000 grant to a Cedars-Sinai Heart Institute team investigating whether an experimental cardiac stem cell treatment could be used to treat Duchenne muscular dystrophy patients who have developed heart disease.

30 May 2013

Tafinlar, Mekinist get FDA approval to treat patients with advanced melanoma

The U.S. Food and Drug Administration today approved two new drugs, Tafinlar (dabrafenib) and Mekinist (trametinib), for patients with advanced (metastatic) or unresectable (cannot be removed by surgery) melanoma, the most dangerous type of skin cancer.

30 May 2013

Columbia University, Chinese Center for Disease Control to open joint pathogen discovery lab in Beijing

The Center for Infection and Immunity at Columbia University's Mailman School of Public Health and the National Institute for Viral Disease Control and Prevention within the Chinese Center for Disease Control and Prevention will open a Joint Research Laboratory for Pathogen Discovery to conduct surveillance, identify new infectious microbes, establish novel platforms for diagnostics, and develop drugs and vaccines to treat diseases in humans and animals.

29 May 2013

PathCentral unveils AP Anywhere Express Anatomic Pathology Laboratory Information System

PathCentral, a technology-enabled company dedicated to the success of the pathology community, today unveiled its AP Anywhere Express Anatomic Pathology Laboratory Information System.

28 May 2013

New Smartphone app helps maintain accurate records to manage diabetes

Vital improvements can be made to patients diabetes control, by ensuring a recent blood glucose history is available to their Specialist Nurse. Traditionally patients have recorded their results in a paper logbook but now the new app from GlucoMen is a fantastic alternative using Smartphone technology to ensure a complete and accurate record.

28 May 2013

New deal to bring Mendor's all-in-one blood glucose monitoring system to nine European markets

Mendor, the Finnish diabetes technology company, is proud to announce its partnership with A. Menarini Diagnostics S.r.l, one of Europe's leading diagnostics companies in the field of diabetes.

28 May 2013

New analysis shows Chinese Pharmaceutical Market revenues to more than double by 2016

Rising incomes, improving healthcare infrastructure, and enhanced insurance systems have propelled the Chinese pharmaceutical market to become the third-largest in the world.

28 May 2013

New app for iPhone helps detect toxins, proteins, bacteria and viruses

Researchers and physicians in the field could soon run on-the-spot tests for environmental toxins, medical diagnostics, food safety and more with their smartphones.

27 May 2013

Researchers develop multicolor fluorescence labeling method to identify tumor specific miRNAs

In recent years, microRNAs and other non-coding RNAs are small molecules that help control the expression of specific proteins. In recent years they have emerged as disease biomarkers.

27 May 2013

OPKO reports more than 50% enrollment in phase 3 trial of Rayaldy for treatment of secondary hyperparathyroidism

OPKO Health, Inc., has surpassed 50% enrollment in the first phase 3 trial of RayaldyTM to treat patients with secondary hyperparathyroidism (SHPT), stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency.

24 May 2013

TSRI scientists devise new technique to find therapeutic antibodies

Scientists at The Scripps Research Institute have devised a powerful new technique for finding antibodies that have a desired biological effect. Antibodies, which can bind to billions of distinct targets, are already used in many of the world's best-selling medicines, diagnostics and laboratory reagents.

24 May 2013

Researchers use data to identify different forms of prostate cancers and effective treatment options

Some prostate cancer patients unnecessarily undergo surgery or harsh treatments because science fails to identify the differences between slow-growing and aggressive forms of the disease. Researchers at Case Western Reserve University and Johns Hopkins Medical Institutes are developing technology that allows patients to safely choose to do nothing, opt for relatively mild treatments or take drastic measures.

24 May 2013

FDA approves Tina-quant HbA1cDx assay for diagnosis of diabetes

Today the U.S. Food and Drug Administration announced that it is allowing marketing of the COBAS INTEGRA 800 Tina-quant HbA1cDx assay (Tina-quant HbA1cDx assay) for the diagnosis of diabetes by health care professionals.

24 May 2013

Diagnostics News and Research

NanoString Technologies to present clinical study of Prosigna Breast Cancer Assay at ASCO 2013

Experts to kick off Big Ten Cancer Research Consortium in Chicago

Five studies on breast, colon and colorectal cancer to be presented at ASCO Annual Meeting

Viral load: A new technique that helps doctors diagnose chronic viral diseases

Be ready for the next generation of cancer treatments

Apnix Sleep Diagnostics updates comprehensive sleep apnea treatments

GE Healthcare receives FDA clearance for Brivo Plus C-arm

Cedars-Sinai team awarded grant to study cardiac stem cell treatment for Duchenne muscular dystrophy

Tafinlar, Mekinist get FDA approval to treat patients with advanced melanoma

Columbia University, Chinese Center for Disease Control to open joint pathogen discovery lab in Beijing

PathCentral unveils AP Anywhere Express Anatomic Pathology Laboratory Information System

New Smartphone app helps maintain accurate records to manage diabetes

New deal to bring Mendor's all-in-one blood glucose monitoring system to nine European markets

New analysis shows Chinese Pharmaceutical Market revenues to more than double by 2016

New app for iPhone helps detect toxins, proteins, bacteria and viruses

Researchers develop multicolor fluorescence labeling method to identify tumor specific miRNAs

OPKO reports more than 50% enrollment in phase 3 trial of Rayaldy for treatment of secondary hyperparathyroidism

TSRI scientists devise new technique to find therapeutic antibodies

Researchers use data to identify different forms of prostate cancers and effective treatment options

FDA approves Tina-quant HbA1cDx assay for diagnosis of diabetes

Industry Focus eBook - Biotechnology (4th edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News